tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RLMD Stock Latest News

Relmada Therapeutics assumed at Outperform from Market Perform at Leerink
The FlyRelmada Therapeutics assumed at Outperform from Market Perform at Leerink
20d ago
RLMD
Relmada’s New Phase 3 Bladder Cancer Trial Adds a Fresh Catalyst to Its Pipeline
PremiumCompany Announcements
Relmada’s New Phase 3 Bladder Cancer Trial Adds a Fresh Catalyst to Its Pipeline
27d ago
RLMD
Relmada Therapeutics provides regulatory update on FDA alignment for NDV-01
PremiumThe Fly
Relmada Therapeutics provides regulatory update on FDA alignment for NDV-01
1M ago
RLMD
Relmada’s BOOST Phase 3 Bladder Cancer Trial Sets Up a New Catalyst for RLMD Investors
PremiumCompany Announcements
Relmada’s BOOST Phase 3 Bladder Cancer Trial Sets Up a New Catalyst for RLMD Investors
1M ago
RLMD
Ibio, RLMD, SEE, OLLI, Invivyd Trending With Analysts
PremiumWeekend Updates
Ibio, RLMD, SEE, OLLI, Invivyd Trending With Analysts
2M ago
SEE
IBIO
Arcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
PremiumThe FlyArcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
2M ago
CMI
SEE
Relmada Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Relmada Therapeutics initiated with a Buy at Jefferies
2M ago
RLMD
Relmada Therapeutics Amends Executive Employment Agreements
Premium
Company Announcements
Relmada Therapeutics Amends Executive Employment Agreements
2M ago
8K
RLMD
Relmada Therapeutics to present NDV-01 Phase 2 data at SUO meeting
PremiumThe Fly
Relmada Therapeutics to present NDV-01 Phase 2 data at SUO meeting
2M ago
RLMD
Mizuho upgrades Relmada to Outperform with ‘more upside’ ahead
PremiumThe Fly
Mizuho upgrades Relmada to Outperform with ‘more upside’ ahead
3M ago
RLMD
Relmada Therapeutics upgraded to Outperform from Neutral at Mizuho
PremiumThe Fly
Relmada Therapeutics upgraded to Outperform from Neutral at Mizuho
3M ago
RLMD
Relmada Therapeutics’ Earnings Call Highlights Clinical and Financial Success
PremiumCompany Announcements
Relmada Therapeutics’ Earnings Call Highlights Clinical and Financial Success
3M ago
RLMD
Relmada Therapeutics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsRelmada Therapeutics Reports Q3 2025 Financial Results
3M ago
RLMD
Relmada Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Relmada Therapeutics Reports Q3 2025 Financial Results
3M ago
8K
RLMD
Is RLMD a Buy, Before Earnings?
Premium
Pre-Earnings
Is RLMD a Buy, Before Earnings?
3M ago
RLMD
Relmada Therapeutics Announces $100M Stock Offering
PremiumCompany Announcements
Relmada Therapeutics Announces $100M Stock Offering
3M ago
8K
RLMD
Relmada Therapeutics announces FDA feedback on study paths for NDV-01
PremiumThe Fly
Relmada Therapeutics announces FDA feedback on study paths for NDV-01
3M ago
RLMD
Relmada Therapeutics prices 40.1M shares at $2.20 in underwritten offering
PremiumThe Fly
Relmada Therapeutics prices 40.1M shares at $2.20 in underwritten offering
3M ago
RLMD
Relmada Therapeutics Receives FDA Feedback on NDV-01 Trials
PremiumCompany Announcements
Relmada Therapeutics Receives FDA Feedback on NDV-01 Trials
3M ago
8K
RLMD
Relmada Therapeutics appoints Max Kates to clincal advisory board
PremiumThe FlyRelmada Therapeutics appoints Max Kates to clincal advisory board
4M ago
RLMD
Relmada Therapeutics Updates Corporate Presentation on NDV-01
Premium
Company Announcements
Relmada Therapeutics Updates Corporate Presentation on NDV-01
5M ago
8K
RLMD
Relmada Therapeutics regains compliance with Nasdaq min bid price requirement
Premium
The Fly
Relmada Therapeutics regains compliance with Nasdaq min bid price requirement
5M ago
RLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >